A Novel Multi-Target Drug Screening Strategy Directed Against Key Proteins of DAPk Family

Author(s): Syam B. Nair, Shaik M. Fayaz, Golgodu K. Rajanikant

Journal Name: Combinatorial Chemistry & High Throughput Screening
Accelerated Technologies for Biotechnology, Bioassays, Medicinal Chemistry and Natural Products Research

Volume 16 , Issue 6 , 2013

Become EABM
Become Reviewer
Call for Editor


Screening and identifying multi-target ligands becomes a daunting task when there are very few matching pharmacophoric features among the proteins. Herein, we describe a novel screening strategy to identify multi-target ligands for proteins having varying pharmacophoric features with their ligands. This strategy was adopted to identify multi-target ligands for death-associated protein kinase (DAPk) family. The role of the kinase activity of DAPk in eukaryotic cell apoptosis and the ability of bioavailable DAPk inhibitors to rescue neuronal death after brain injury have made it a drug-discovery target for neurodegenerative disorders. In this work, we employed a novel strategy using the existing computational approaches to design multi-target inhibitors, which can potentially inhibit one or any combination of the three DAPk family members. The strategy employs a combination of merged pharmacophore matching, database screening and molecular docking to reliably identify potential multi-target inhibitors targeted against DAPk protein family.

Keywords: DAPk1, DRP1, merged pharmacophore, multi-target, polypharmacology, ZIPk.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 30 April, 2013
Page: [449 - 457]
Pages: 9
DOI: 10.2174/1386207311316060005
Price: $65

Article Metrics

PDF: 15